Alvin Schmaier, MD
Schedule an Appointment
Biography
- Director, Seidman Cancer Center Lab, UH Cleveland Medical Center
- Director, Adult Hemophilia Program, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Expertise
- Anticoagulant Management
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Benign Hematology
- Hemostasis and Thrombosis
- Hereditary Angioedema
- Porphyria
Languages Spoken
English
Office Locations
Patient Experience Reviews
4.8 out of 5
47 Ratings
Patient Comments (9)
Reviewed On 12/1/2022
Excellent doctor.
Reviewed On 11/1/2022
This was an excellent visit! First time with this doctor and highly recommend
Reviewed On 10/1/2022
Dr. Schmaier is an extremely thorough, dr., working at the highest level of acumen and integrity in his profession.
Reviewed On 9/2/2022
Dr. Schmaier is excellent. He listens and takes the time to explain complicated issues. He answers all questions and I would recommend highly!
Reviewed On 9/2/2022
My Father thanks the doctor for his expertise and care.
Reviewed On 8/1/2022
Best there is!
Reviewed On 7/1/2022
Good
Reviewed On 4/1/2022
This was my first visit to see Dr. Schmaier. He was such a kind and understand man. He made me feel at ease with the appointment and what I could expect with treatment.
Reviewed On 4/1/2022
Dr. Schmaier is the BEST. He understands my husband's health journey and truly cares for him. We're blessed to have his on *** team.
Certifications & Memberships
- Medical Oncology - American Board of Internal Medicine
- Hematology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Research Fellowship | Hematology/Oncology
Hematology/Oncology - Temple University Hospital (1979 - 1980)
Fellowship | Hematology/Oncology
Hematology/Oncology - Hospital Of The University Of Pennsylvania (1977 - 1979)
Residency | Internal Medicine
Internal Medicine - Temple University Hospital (1975 - 1977)
Internship | Internal Medicine
Internal Medicine - Temple University (1974 - 1975)
Medical Education
Virginia Commonwealth University School Of Medicine (1974)
Undergraduate
University Of Virginia (1970)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Alvin Schmaier disclosed the following Outside Relationships with Industry:
- - Lippincott Publishers - Intellectual Property